Gr-1+CD11b+ cells as an accelerator of sepsis stemming from Pseudomonas aeruginosa wound infection in thermally injured mice

Journal of Leukocyte Biology

Volumn 83, Issue 6, 2008, Pages 1354-1362

  Kobayashi, Makiko ^a,b   Yoshida, Tsuyoshi ^a   Takeuchi, Dan ^a   Jones, Vickie C ^a   Shigematsu, Kenji ^a   Herndon, David N ^b   Suzuki, Fujio ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

defensin; Thermal injury

Indexed keywords

BETA DEFENSIN; CD11B ANTIGEN; POLYPEPTIDE ANTIBIOTIC AGENT; CHEMOKINE RECEPTOR; GR 1 PROTEIN, MOUSE; GR-1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BURN; CELL FUNCTION; CELL ISOLATION; COLONY FORMING UNIT; CONTROLLED STUDY; EPIDERMIS CELL; GR 1 CD11B CELL; INFECTION SENSITIVITY; INHIBITION KINETICS; KERATINOCYTE; MALE; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA; SEPSIS; SKIN CELL; SKIN INFECTION; THERMAL INJURY; TISSUE HOMOGENATE; WOUND INFECTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; GRAM NEGATIVE INFECTION; PHYSIOLOGY;

MURINAE; MUS; PSEUDOMONAS AERUGINOSA;

ANIMALS; ANTIGENS, CD11B; BETA-DEFENSINS; BURNS; MALE; MICE; MICE, INBRED BALB C; PSEUDOMONAS INFECTIONS; RECEPTORS, CHEMOKINE; SEPSIS; WOUND INFECTION;

EID: 45949091759     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0807541     Document Type: Article

References (43)

1. Tredget, E. E., Shankowsky, H. A., Rennie, R., Burrell, R. E., Logsetty, S. (2004) Pseudomonas infections in the thermally injured patient. Burns 30, 3-26.
2. Monafo, W. W. (1996) Initial management of burns. N. Engl. J. Med. 335, 1581-1586.
3. Church, D., Elsayed, S., Reid, O., Winston, B., Lindsay, R. (2006) Burn wound infections. Clin. Microbiol. Rev. 19, 403-434.
4. Heggers, J. P., Hawkins, H., Edgar, P., Villarreal, C., Herndon, D. N. (2002) Treatment of infection in burns. In Total Burn Care (D. N. Herndon, ed.), Edinburgh, UK, Saunders, 120-169.
5. Stieritz, D. D., Holder, I. A. (1975) Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J. Infect. Dis. 131, 688-691.
6. Medzhitov, R., Janeway Jr., C. A. (1997) Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9, 4-9.
7. Akira, S., Uematsu, S., Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
8. Sester, D. P., Stacey, K. J., Sweet, M. J., Beasley, S. J., Cronau, S. L., Hume, D. A. (1999) The actions of bacterial DNA on murine macrophages. J. Leukoc. Biol. 66, 542-548.
9. Rothfuchs, A. G., Gigliotti, D., Palmblad, K., Andersson, U., Wigzell, H., Rottenberg, M. E. (2001) IFN-α/β-dependent, IFN-γ secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J. Immunol. 167, 6453-6461.
10. Tanaka, H., Miyazaki, S., Sumiyama, Y., Kakiuchi, T. (2004) Role of macrophages in a mouse model of postoperative MRSA enteritis. J. Surg. Res. 118, 114-121.
11. Tsuda, Y., Takahashi, H., Kobayashi, M., Hanafusa, T., Herndon, D. N., Suzuki, F. (2004) Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 21, 215-226.
12. Takahashi, H., Tsuda, Y., Takeuchi, D., Kobayashi, M., Herndon, D. N., Suzuki, F. (2004) Influence of systemic inflammatory response syndrome on host resistance against bacterial infections. Crit. Care Med. 32, 1879-1885.
13. Ganz, T. (2004) Antimicrobial polypeptides. J. Leukoc. Biol. 75, 34-38.
14. Levy, O. (2004) Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes. J. Leukoc. Biol. 76, 909-925.
15. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., Gallo, R. L. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457.
16. Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., Leung, D. Y. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151-1160.
17. Putsep, K., Carlsson, G., Boman, H. G., Andersson, M. (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360, 1144-1149.
18. Murakami, M., Lopez-Garcia, B., Braff, M., Dorschner, R. A., Gallo, R. L. (2004) Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172, 3070-3077.
19. Sawamura, D., Goto, M., Shibaki, A., Akiyama, M., McMillan, J. R., Abiko, Y., Shimizu, H. (2005) β Defensin-3 engineered epidermis shows highly protective effect for bacterial infection. Gene Ther. 12, 857-861.
20. Bellm, L., Lehrer, R. I., Ganz, T. (2000) Protegrins: new antibiotics of mammalian origin. Expert Opin. Investig. Drugs 9, 1731-1742.
21. Steinstraesser, L., Tack, B. F., Waring, A. J., Hong, T., Boo, L. M., Fan, M. H., Remick, D. I., Su, G. L., Lehrer, R. I., Wang, S. C. (2002) Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob. Agents Chemother. 46, 1837-1844.
22. Milner, S. M., Ortega, M. R. (1999) Reduced antimicrobial peptide expression in human burn wounds. Burns 25, 411-413.
23. Häkkinen, L., Koivisto, L., Larjava, H. (2001) An improved method for culture of epidermal keratinocytes from newborn mouse skin. Methods Cell Sci. 23, 189-196.
24. Breuss, J. M., Gallo, J., DeLisser, H. M., Klimanskaya, I. V., Folkesson, H. G., Pittet, J. F., Nishimura, S. L., Aldape, K., Landers, D. V., Carpenter, W., et al. (1995) Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J. Cell Sci. 108, 2241-2251.
25. Ryan, M. A., Akinbi, H. T., Serrano, A. G., Perez-Gil, J., Wu, H., McCormack, F. X., Weaver, T. E. (2006) Antimicrobial activity of native and synthetic surfactant protein B peptides. J. Immunol. 176, 416-425.
26. Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., Bronte, V. (2004) Derangement of immune responses by myeloid suppressor cells. Cancer Immunol. Immunother. 53, 64-72.
27. + myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 176, 2085-2094.
28. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66, 1123-1131.
29. Sica, A., Bronte, V. (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155-1166.
30. Zanetti, M. (2004) Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39-48.
31. Noel, J. G., Guo, X., Wells-Byrum, D., Schwemberger, S., Caldwell, C. C., Ogle, C. K. (2005) Effect of thermal injury on splenic myelopoiesis. Shock 23, 115-122.
32. + population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 1463-1474.
33. Melani, C., Chiodoni, C., Forni, G., Colombo, M. P. (2003) Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102, 2138-2145.
34. Serafini, P., Borrello, I., Bronte, V. (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16, 53-65.
35. Liu, C., Yu, S., Kappes, J., Wang, J., Grizzle, W. E., Zinn, K. R., Zhang, H. G. (2007) Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 109, 4336-4342.
36. + immature myeloid suppressor cells. Int. Immunol. 14, 1125-1134.
37. Paraiso, K. H., Ghansah, T., Costello, A., Engelman, R. W., Kerr, W. G. (2007) Induced SHIP deficiency expands myeloid regulatory cells and abrogates graft-versus-host disease. J. Immunol. 178, 2893-2900.
38. Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., Carbone, D. P. (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92, 4150-4166.
39. + T cell responses by dysregulating antigen-presenting cell maturation. J. Immunol. 162, 5728-5737.
40. Infanger, M., Schmidt, O., Kossmehl, P., Grad, S., Ertel, W., Grimm, D. (2004) Vascular endothelial growth factor serum level is strongly enhanced after burn injury and correlated with local and general tissue edema. Burns 30, 305-311.
41. Rumbaugh, K. P., Colmer, J. A., Griswold, J. A., Hamood, A. N. (2001) The effects of infection of thermal injury by Pseudomonas aeruginosa PAO1 on the murine cytokine response. Cytokine 16, 160-168.
42. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
43. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.